The Relationship between Homocysteine, Obesity, Glucose and Lipid Profiles in Small-Breed Dogs

다국어 초록 (Multilingual Abstract)

This study was conducted to evaluate whether plasma homocysteine levels were related to obesity or its contributing factors (e.g., lipids, insulin, glucose, glucagon, and fructosamine) in dogs without systemic diseases such as diabetes or renal failure. For achieving our study goal, 100 client-owned dogs without systemic diseases were enrolled in this study. Fasting glucose concentration; lipid profile (i.e., total triglycerides [TG], total cholesterol [TC], highdensity lipoprotein cholesterol [HDL-C], and low-density lipoprotein cholesterol [LDL-C]); and fructosamine, insulin,and glucagon levels were determined. The dogs were subdivided by the body condition score (BCS). The median levels of homocysteine were considerably higher in obese dogs than in lean and normal dogs. Interestingly, not only was homocysteine positively associated with the level of HDL-C, but also found to have a significant positive association with TG, TC, plasma glucagon levels, and fructosamine. In contrast, LDL-C, fasting glucose and insulin did not show any association with homocysteine. The findings presented, suggest that elevated levels of homocysteine may play a biological role in obesity in dogs.

참고문헌 (Reference)

1 Reimers TJ, "Validation of a rapid solid-phase radioimmunoassay for canine, bovine, and equine insulin" 43 : 1274-1278, 1982

2 Robillon JF, "Type 1 diabetes mellitus and homocyst(e)ine" 20 : 494-496, 1994

3 Herrmann W, "The importance of hyperhomocysteinemia as a risk factor for diseases: an overview" 39 : 666-674, 2001

4 Puavilai W, "The accuracy in using modified Friedewald equation to calculate LDL from non-fast triglyceride: a pilot study" 92 : 182-187, 2009

5 Ercan M, "Role of plasma viscosity and plasma homocysteine level on hyperinsulinemic obese female subjects" 38 : 227-234, 2008

6 Mazza A, "Reduced serum homocysteine levels in type 2 diabetes" 15 : 118-124, 2005

7 Barazzoni R, "Protein metabolism in glucagonoma" 42 : 326-329, 1999

8 Chandler ML, "Prospective evaluation of a peripherally administered three-in-one parenteral nutrition product in dogs" 47 : 518-523, 2006

9 Uysal O, "Plasma total homocysteine level and its association with carotid intima-media thickness in obesity" 28 : 928-934, 2005

10 Wollesen F, "Plasma total homocysteine and cysteine in relation to glomerular filtration rate in diabetes mellitus" 55 : 1028-1035, 1999

11 McMichael MA, "Plasma homocysteine, B vitamins, and amino acid concentrations in cats with cardiomyopathy and arterial thromboembolism" 14 : 507-512, 2000

12 Karatela RA, "Plasma homocysteine in obese, overweight and normal weight hypertensives and normotensives" 61 : 156-159, 2009

13 Guyard-Dangremont V, "Phospholipid and cholesteryl ester transfer activities in plasma from 14 vertebrate species. Relation to atherogenesis susceptibility" 120 : 517-525, 1998

14 Fruchart JC, "New risk factors for atherosclerosis and patient risk assessment" 109 : 15-19, 2004

15 Bailhache E, "Lipoproteins abnormalities in obese insulinresistant dogs" 52 : 559-564, 2003

16 Maldonado EN, "Lipid and fatty acid composition of canine lipoproteins" 128 : 719-729, 2001

17 Budak N, "Is plasma homocysteine level associated with metabolic syndrome components in adolescents?" 7 : 357-362, 2009

18 Schalinske KL., "Interrelationship between diabetes and homocysteine metabolism: hormonal regulation of cystathionine beta-synthase" 61 : 136-138, 2003

19 Fonseca VA, "Insulin sensitivity and plasma homocysteine concentrations in non-diabetic obese and normal weight subjects" 167 : 105-109, 2003

20 Barth RJ, "Insulin resistance, obesity and the metabolic syndrome" 22-27, 2011

21 Hess RS., "Insulin resistance in dogs" 40 : 309-316, 2010

22 Mikael LG, "Hyperhomocysteinemia is associated with hypertriglyceridemia in mice with methylenetetrahydrofolate reductase deficiency" 98 : 187-194, 2009

23 Liao D, "Hyperhomocysteinemia decreases circulating high-density lipoprotein by inhibiting apolipoprotein A-I Protein synthesis and enhancing HDL cholesterol clearance" 99 : 598-606, 2006

24 Suematsu N, "Hyperhomocysteinemia alters cardiac substrate metabolism by impairing nitric oxide bioavailability through oxidative stress" 115 : 255-262, 2007

25 Hofmann MA, "Hyperhomocyst(e)inemia and endothelial dysfunction in IDDM" 21 : 841-848, 1998

26 Jacobs RL, "Hyperglucagonemia in rats results in decreased plasma homocysteine and increased flux through the transsulfuration pathway in liver" 276 : 43740-43747, 2001

27 Vizzardi E, "Homocysteine: a casual link with heart failure?" 100 : 421-427, 2009

28 Finch JM, "Homocysteine, cardiovascular inflammation, and myocardial remodeling" 10 : 241-245, 2010

29 Rossi S, "Homocysteine measurement by an enzymatic method and potential role of homocysteine as a biomarker in dogs" 20 : 644-649, 2008

30 Obeid R, "Homocysteine and lipids: S-adenosyl methionine as a key intermediate" 583 : 1215-1225, 2009

31 Welch GN, "Homocysteine and atherothrombosis" 338 : 1042-1050, 1998

32 Delpierre G, "Fructosamine3-kinase is involved in an intracellular deglycationpathway in human erythrocytes" 365 : 801-808, 2002

33 Meigs JB, "Fasting plasma homocysteine levels in the insulin resistance syndrome: the Framingham offspring study" 24 : 1403-1410, 2001

34 Davison LJ, "Evaluation of two point-of-care analysers for measurement of fructosamine or haemoglobin A1c in dogs" 43 : 526-532, 2002

35 Pinkney JH, "Endothelial dysfunction: cause of the insulin resistance syndrome" 46 (46): 9-13, 1997

36 Velez-Carrasco W, "Dietary methionine effects on plasma homocysteine and HDL metabolism in mice" 19 : 362-370, 2008

37 Mawby DI, "Comparison of various methods for estimating body fat in dogs" 40 : 109-114, 2004

38 Son HR, "Comparison of dualenergy x-ray absorptiometry and measurement of total body water content by deuterium oxide dilution for estimating body composition in dogs" 59 : 529-532, 1998

39 Wilt TJ, "Carotid atherosclerosis in men with low levels of HDL cholesterol" 28 : 1919-1925, 1997

40 Björck J, "Associations between serum insulin and homocysteine in a Swedish population-a potential link between the metabolic syndrome and hyperhomocysteinemia: the Skaraborg project" 55 : 1007-1013, 2006

41 Veiga AP, "Association of canine obesity with reduced serum levels of C-reactive protein" 20 : 224-228, 2008

42 Herrmann M, "A review of homocysteine and heart failure" 8 : 571-576, 2006